Impact of the COVID-19 epidemic on patient management in the oncology-haematology setting, and on psychological repercussions among patients and caregivers

{"level_sex_clusion_I":[{"value":"Male","concept":{"vocab":"MeSH","vocabURI":"D008297"}},{"value":"Female","concept":{"vocab":"MeSH","vocabURI":"D005260"}}],"level_age_clusion_I":[{"value":"Young Adult (19 to 24 years)","concept":{"vocab":"MeSH","vocabURI":"D055815"}},{"value":"Adult (25 to 44 years)","concept":{"vocab":"MeSH","vocabURI":"D000328"}},{"value":"Middle Aged (45 to 64 years)","concept":{"vocab":"MeSH","vocabURI":"D008875"}},{"value":"Aged (65 to 79 years)","concept":{"vocab":"MeSH","vocabURI":"D000368"}},{"value":"Aged, 80 and over (80 years and more)","concept":{"vocab":"MeSH","vocabURI":"D000369"}}],"level_type_clusion_I":"Patients population","level_type_clusion_other":"","clusion_I":"Adult patient, treated for a solid tumour or haematological malignancy - Receiving or needing to receive medical cancer treatment delivered in an outpatient oncology setting at participating sites: treatment initiated before or during the COVID-19 pandemy - The patient does not object to taking part in the study - Patient not deprived of their liberty or under supervision - Female patient with no associated geographical, social or psychopathological condition liable to compromise the patient’s ability to take part in the study","clusion_E":""}